We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants.
This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology.
MedTech Innovator is the world’s largest and most prestigious accelerator for medical device startups. Over the next four months, HAPPE Spine will receive targeted mentorship, strategic support, and direct exposure to key industry stakeholders, including investors, healthcare providers, and leading manufacturers. The program culminates in pitch opportunities at premier industry events like The MedTech Conference and the MedTech Strategist Innovation Summit, where cohort companies will compete for a share of $800,000 in non-dilutive funding.
We congratulate the entire HAPPE Spine team on this milestone and look forward to supporting their continued growth.